Sabrina Falkowski
Association François Aupetit(FR)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial(2021)218 cited
- → Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma—Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study(2016)36 cited
- → Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship(2017)32 cited
- → Therapeutic Drug Monitoring of Everolimus in Oncology: Evidences and Perspectives(2019)24 cited
- → Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies(2009)22 cited
- → First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?(2021)14 cited
- → Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study(2017)13 cited
- → Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma(2022)6 cited
- → Effect of genetic polymorphisms in CYP3A4, CYP3A5, and m-TOR on everolimus blood exposure and clinical outcomes in cancer patients(2020)5 cited
- → Association of single nucleotide polymorphisms (SNPs) in CYP17A1 and SLCO2B1 genes and clinical outcome in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: results of the ABIGENE prospective study.(2018)5 cited